Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare immune dysregulation disease with immunodeficiency characterized by severe, progressive infantile onset inflammatory bowel disease with pancolitis, perianal disease (ulceration, fistulae), recurrent respiratory, genitourinary and cutaneous infections, arthritis and a high risk of B-cell lymphoma.
Biomarker and diagnostic research for IL10-related early-onset inflammatory bowel disease has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for IL10-related early-onset inflammatory bowel disease.
183 publications have been identified in PubMed for IL10-related early-onset inflammatory bowel disease. Research spans Review / Meta-Analysis (36%), Basic Science / Preclinical (26%), and Epidemiology / Natural History (17%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 66 | 36% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:36 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about IL10-related early-onset inflammatory bowel disease
Laboratory research |
48 |
26% |
Disease patterns and progression | 32 | 17% |
Clinical study results | 19 | 10% |
Patient case studies | 13 | 7% |
Testing and diagnosis research | 3 | 2% |
New treatment approaches | 2 | 1% |
Tseng-Rogenski SS (2026). [PMID: 41307580](https://pubmed.ncbi.nlm.nih.gov/41307580/). *Human molecular genetics*. [Basic Science / Preclinical]
Liu S (2026). [PMID: 41772119](https://pubmed.ncbi.nlm.nih.gov/41772119/). *Nat Rev Gastroenterol Hepatol*. [Review / Meta-Analysis]
Singh P (2026). [PMID: 41689683](https://pubmed.ncbi.nlm.nih.gov/41689683/). *Digestive diseases and sciences*. [Epidemiology / Natural History]
Srivastava H (2026). [PMID: 41790596](https://pubmed.ncbi.nlm.nih.gov/41790596/). *Expert Rev Clin Immunol*. [Review / Meta-Analysis]
Haghipanah M (2026). [PMID: 41547964](https://pubmed.ncbi.nlm.nih.gov/41547964/). *Pediatric research*. [Epidemiology / Natural History]
Leach ST (2026). [PMID: 41713485](https://pubmed.ncbi.nlm.nih.gov/41713485/). *Expert review of gastroenterology & hepatology*. [Case Report / Case Series]
Hou S (2026). [PMID: 41605881](https://pubmed.ncbi.nlm.nih.gov/41605881/). *Gut Microbes*. [Basic Science / Preclinical]
Chen Y (2026). [PMID: 40910275](https://pubmed.ncbi.nlm.nih.gov/40910275/). *Gut and liver*. [Epidemiology / Natural History]
Tariq R (2026). [PMID: 41805835](https://pubmed.ncbi.nlm.nih.gov/41805835/). *J Clin Gastroenterol*. [Review / Meta-Analysis]
Rana A (2026). [PMID: 41137522](https://pubmed.ncbi.nlm.nih.gov/41137522/). *J Sci Food Agric*. [Review / Meta-Analysis]